Medicare Enrolled

Dr. Brian Costell, M.D.

Neurology · Boca Raton, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
9970 CENTRAL PARK BLVD N, Boca Raton, FL 33428
5614821027
In practice since 2006 (19 years)
NPI: 1174563688 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Costell

Dr. Brian Costell is a neurology specialist in Boca Raton, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Costell performed 153,554 Medicare services across 1,734 unique beneficiaries.

Between the years covered by Open Payments, Dr. Costell received a total of $473,436 from 103 pharmaceutical and/or device companies across 2557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Costell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 0% volume in FL $473,436 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 90900 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
153,554
Medicare services
Top 0% in FL for neurology
1,734
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,082 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Lecanemab injection, 1 mg
Administration of a 1 mg dose of lecanemab-irmb via injection.
101,664 $1 $14
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
38,400 $5 $24
Injection, eptinezumab-jjmr, 1 mg 10,700 $13 $31
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
638 $95 $562
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
361 $144 $788
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
178 $50 $280
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
171 $131 $772
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
171 $106 $626
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
169 $131 $730
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
153 $52 $310
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
145 $17 $93
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
142 $79 $433
Injection, methylprednisolone acetate, 40 mg 81 $6 $11
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
63 $170 $960
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
51 $23 $132
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
46 $13 $72
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
44 $82 $494
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
41 $142 $803
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $64 $397
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
34 $232 $1,311
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 33 $62 $348
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
31 $85 $495
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
28 $11 $60
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
24 $109 $607
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
23 $1 $4
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
23 $4 $24
Punch biopsy of additional skin growth
A small circular tool is used to remove a sample of an extra skin growth for laboratory examination.
22 $49 $265
New patient office visit, complex (60-74 min) 22 $174 $976
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
21 $31 $245
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
14 $215 $1,115
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
11 $104 $563
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
11 $201 $1,116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
98.7% medium
1.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$473,436
Total received (2018-2024)
Avg $67,634/year across 7 years
Top 1% in FL for neurology
103
Companies
2,557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$441,635 (93.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,497 (5.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,303 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65,665
2023
$31,272
2022
$33,902
2021
$107,771
2020
$86,810
2019
$76,899
2018
$71,117

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$96,719
Amgen Inc.
$79,442
Allergan, Inc.
$43,409
Eisai Inc.
$40,191
AbbVie Inc.
$38,027
ABBVIE INC.
$37,043
Allergan Inc.
$33,987
Teva Pharmaceuticals USA, Inc.
$27,105
Biohaven Pharmaceuticals, Inc.
$18,459
Assertio Therapeutics, Inc.
$11,093
Lundbeck LLC
$5,003
Biohaven Pharmaceutical Holding Company Ltd.
$4,921
Sunovion Pharmaceuticals Inc.
$3,783
AbbVie, Inc.
$3,590
Supernus Pharmaceuticals, Inc.
$3,331
Novartis Pharmaceuticals Corporation
$2,647
ARGENX US, INC.
$2,562
UCB, Inc.
$1,777
CATALYST PHARMACEUTICALS, INC.
$1,722
EMD Serono, Inc.
$1,461
GENZYME CORPORATION
$1,265
Alexion Pharmaceuticals, Inc.
$947
Biogen, Inc.
$839
PFIZER INC.
$736
Genentech USA, Inc.
$709
Takeda Pharmaceuticals U.S.A., Inc.
$674
Amneal Pharmaceuticals LLC
$671
Abbott Laboratories
$523
Egalet US Inc
$503
US WorldMeds, LLC
$496
CSL Behring
$488
Merz Pharmaceuticals, LLC
$424
Neurelis, Inc.
$380
ACADIA Pharmaceuticals Inc
$377
Avanir Pharmaceuticals, Inc.
$370
Mallinckrodt Hospital Products Inc.
$354
Janssen Pharmaceuticals, Inc
$350
Acorda Therapeutics, Inc
$350
Neurocrine Biosciences, Inc.
$333
Octapharma USA, Inc.
$331
ANI Pharmaceuticals, Inc.
$320
Celgene Corporation
$318
Grifols USA, LLC
$286
SCILEX PHARMACEUTICALS INC.
$285
Piramal Imaging Limited
$284
SK Life Science, Inc.
$262
Alnylam Pharmaceuticals Inc.
$247
Harmony Biosciences LLC
$244
MDD US Operations, LLC
$240
IMPEL PHARMACEUTICALS INC.
$232
MITSUBISHI TANABE PHARMA AMERICA, INC.
$225
Ipsen Biopharmaceuticals, Inc
$223
Upsher-Smith Laboratories LLC
$189
JAZZ PHARMACEUTICALS INC.
$153
EISAI INC.
$141
LivaNova USA, Inc.
$124
UPSHER-SMITH LABORATORIES LLC
$122
Merz North America, Inc.
$121
Alfasigma USA, Inc.
$108
Merck Sharp & Dohme Corporation
$102
E.R. Squibb & Sons, L.L.C.
$101
Kyowa Kirin, Inc.
$100
Indivior Inc.
$98
Bausch Health US, LLC
$85
Akcea Therapeutics, Inc.
$77
Medtronic, Inc.
$75
Aprecia Pharmaceuticals, LLC
$70
Adamas Pharmaceuticals, Inc.
$59
Sumitomo Pharma America, Inc.
$59
Horizon Therapeutics plc
$58
Otsuka America Pharmaceutical, Inc.
$58
Impax Laboratories, Inc.
$54
AQUESTIVE THERAPEUTICS, INC.
$54
Mallinckrodt Enterprises LLC
$52
KVK-Tech, Inc.
$46
Corium, LLC
$45
ARBOR PHARMACEUTICALS, INC.
$44
Silk Road Medical, Inc.
$44
Saol Therapeutics Inc.
$43
AstraZeneca Pharmaceuticals LP
$38
Scilex Pharmaceuticals Inc.
$37
Promius Pharma LLC
$36
Boston Scientific Corporation
$36
HARMONY BIOSCIENCES LLC
$34
Vertical Pharmaceuticals, LLC
$34
BOSTON SCIENTIFIC CORPORATION
$34
InSightec,Inc
$33
Avion Pharmaceuticals
$31
Arbor Pharmaceuticals, Inc.
$29
Currax Pharmaceuticals LLC
$27
Mylan Specialty L.P.
$24
Xeris Pharmaceuticals, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$20
Dynasplint Systems Inc.
$20
Ultragenyx Pharmaceutical Inc.
$20
SpringWorks Therapeutics, Inc.
$18
Merck Sharp & Dohme LLC
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Shire North American Group Inc
$14
Greenwich Biosciences, Inc.
$13
Vanda Pharmaceuticals Inc.
$13
ASSERTIO THERAPEUTICS, Inc.
$13
Top 3 companies account for 46.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Apokyn · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CONTRAVE · COPAXONE · Cambia · Confirm Rx · DUOPA · DYSPORT · Dhivy · Duopa · Dynasplint · Dysport · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · ETERNA · Edarbi · Enspryng · Epidiolex · Evrysdi · Exablate · FIRDAPSE · Fabhalta · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · GLATIRAMER ACETATE · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTERSTIM · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LORZONE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MEROCEL · MIGRANAL · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Octrode SCS Leads · Ongentys · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REVEAL LINQ · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMPAZAN · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WATCHMAN FLX · Wakix · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.

Equivalent to $308 per 100 Medicare services performed
Looking for a neurology specialist in Boca Raton?
Compare neurologists in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
165
Per 100K population
10.9
County median income
$81,115
Nearest hospital
WEST BOCA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Costell is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Costell experienced with lecanemab injection, 1 mg?
Based on Medicare claims data, Dr. Costell performed 101,664 lecanemab injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Costell receive payments from pharmaceutical companies?
Yes. Dr. Costell received a total of $473,436 from 103 companies across 2,557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costell's costs compare to other neurologists in Boca Raton?
Dr. Costell's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →